Key takeaways
- Bariatric surgery in Korea is a recognized medical treatment, covered by national insurance for eligible residents since 2019.
- Sleeve gastrectomy is the most common procedure — about 75% of cases in 2019–2022 national data.
- A Korean prospective multicenter cohort reported no deaths and early complications in only 0.9% of patients.
- Type 2 diabetes remission reached 80.7% at 1 year and 85.7% at 2 years in that cohort (remission is not a cure).
- Selected older patients (55+) had no significant increase in complications, reoperation, or mortality.
- Safety depends on the full pathway — evaluation, the right procedure, and long-term follow-up — not on cost or speed.
KSMBS registry, 2019–2022
0
Recorded mortality during the four-year registry period
- Leakage: 0.5%
- Bleeding: 0.9%
- Obstruction: 0.5%
The complication figures represent separately reported outcomes and should not be added together or directly compared with composite morbidity rates from other registries.
Source: Lee H, et al. A Nationwide Report on Metabolic and Bariatric Surgery in 2019–2022, KSMBS Database Registry. J Metab Bariatr Surg. 2024;13(1):17–26. See the Why Korea evidence page.
Safety is more than the operation
Bariatric surgery is not only about weight loss. For many patients with severe obesity, type 2 diabetes, hypertension, dyslipidemia, or sleep apnea, it is a medically established treatment that can improve long-term metabolic health.
For international patients considering surgery abroad, safety is one of the most important questions. In Korea, bariatric and metabolic surgery is performed within a structured medical system, supported by national insurance criteria, specialist surgical teams, and postoperative follow-up protocols.
Why Korea?
Korea has developed a standardized medical environment for bariatric and metabolic surgery. Since January 2019, the Korean National Health Insurance Service has provided coverage for eligible patients with severe obesity or obesity-related comorbidities. Bariatric surgery in Korea is therefore treated not as a cosmetic procedure, but as a recognized medical treatment for selected patients.
Evidence note
According to national health insurance data, 9,080 bariatric surgery procedures were recorded in Korea between 2019 and 2022. Sleeve gastrectomy was the most commonly performed procedure, accounting for approximately 75% of cases.
Source: Korean National Health Insurance data, 2019–2022.
Note: Korean national insurance coverage applies to eligible Korean residents. International patients are generally treated as self-paid patients — see the cost guide.
Evidence from Korean clinical studies
Recent Korean studies provide useful safety and outcome data for patients considering bariatric surgery in Korea.
1. National data: bariatric surgery is part of Korea’s medical system
A 2024 review using Korean National Health Insurance data reported that bariatric surgery has been covered by the national insurance system since 2019 for eligible patients. Coverage applies to patients with BMI ≥ 35 kg/m², or BMI ≥ 30 kg/m² with obesity-related comorbidities. Partial reimbursement is also available for patients with type 2 diabetes and BMI 27.5–30 kg/m².
Evidence note
In the same national dataset, patients with health checkups before and after surgery showed an average body weight reduction of 17.9% approximately 6 months after surgery. About 80% of patients lost more than 10% of their body weight, with improvements also observed in fasting glucose and blood pressure.
Source: 2024 review of Korean National Health Insurance data.
2. Safety in older East Asian patients
A 2026 multicenter Korean study evaluated 410 patients who underwent metabolic bariatric surgery at six hospitals, comparing patients aged 55 or older with younger patients. Although the older group had more comorbidities (hypertension, dyslipidemia, type 2 diabetes, pulmonary disease, musculoskeletal disease), their surgical safety outcomes were not significantly worse.
2026 multicenter Korean study (n=410): outcomes by age group. General orientation only.
| Outcome |
Older (55+) |
Younger |
| Overall complication rate | 12.8% | 7.5% |
|---|
| Postoperative hospital stay | 4.1 days | 4.0 days |
|---|
| Reoperation | 0% | — |
|---|
| Mortality | 0% | 0% |
|---|
The study concluded that metabolic bariatric surgery can be a safe and effective option for selected older East Asian patients with obesity. The authors emphasized that age alone should not determine eligibility — frailty, cognitive capacity, nutritional status, and organ function should also be considered.
3. Prospective multicenter Korean evidence
A 2026 prospective multicenter cohort study followed 116 Korean patients who underwent bariatric and metabolic surgery (sleeve gastrectomy and gastric bypass) at nine centers. It reported meaningful weight loss, metabolic improvement, and quality-of-life improvement.
2026 prospective multicenter cohort (n=116): total weight loss and remission. Population-level figures; individual results vary.
| Measure |
1 year |
1.5 years |
2 years |
| Total weight loss | 26.8% | 27.5% | 24.7% |
|---|
| Type 2 diabetes remission | 80.7% | — | 85.7% |
|---|
| Hypertension remission | 50.0% | — | 50.0% |
|---|
| Hyperlipidemia remission | 49.0% | — | 71.4% |
|---|
Evidence note
From a safety perspective, no deaths occurred during the study period. Early postoperative complications within 30 days occurred in only one patient (0.9%), and no Clavien–Dindo grade III or higher complications were reported. Sustained quality-of-life improvements were measured using EQ-5D, IWQOL-lite, OP-scale, and BAROS questionnaires.
Source: 2026 prospective multicenter cohort study, nine Korean centers.
Remission is not the same as a cure: it may occur in selected patients but is not guaranteed and can be lost over time, so long-term follow-up remains necessary. See the bariatric surgery for type 2 diabetes guide.
What makes bariatric surgery safer?
Safety depends on more than the operation itself — it depends on patient selection, surgical expertise, anesthesia assessment, hospital systems, and long-term follow-up. In Korea, a safe pathway usually includes:
- Preoperative evaluation of obesity-related diseases
- Assessment of diabetes, hypertension, dyslipidemia, sleep apnea, fatty liver, and reflux disease
- Endoscopy when appropriate, especially because gastric cancer screening is clinically important in Korea
- Selection of the most appropriate procedure, such as sleeve gastrectomy or gastric bypass
- Nutritional counseling and vitamin/mineral supplementation
- Postoperative monitoring for dehydration, reflux, anemia, marginal ulcer, and nutritional deficiency
- Long-term follow-up for weight maintenance and metabolic outcomes
For older patients, safety assessment should also include frailty, sarcopenia risk, renal function, hydration risk, cognitive status, and nutritional status.
Sleeve gastrectomy and gastric bypass: safety considerations
Sleeve gastrectomy is the most frequently performed procedure in Korea. It reduces stomach volume while preserving intestinal continuity, is often considered technically simpler than bypass, and allows future endoscopic access to the stomach — relevant in Korea where gastric cancer screening is important.
Gastric bypass may offer strong metabolic effects, especially in selected patients with type 2 diabetes. However, it requires more complex anatomical reconstruction and may carry procedure-specific risks such as marginal ulcer, internal hernia, or nutritional deficiency.
The choice should be individualized. BMI, diabetes severity, reflux disease, endoscopic findings, gastric cancer risk, medication use, and patient preference should all be considered.
Safety does not mean zero risk
Bariatric surgery is generally safe when performed in appropriately selected patients by experienced teams, but it is still major surgery. Possible risks include bleeding, leakage, infection, venous thromboembolism, reflux symptoms, ulceration, bowel obstruction, dehydration, anemia, and nutritional deficiencies.
For this reason, patients should not choose surgery based only on price, travel convenience, or expected weight loss. The safety of bariatric surgery depends on the full care pathway: evaluation before surgery, hospital-based surgical care, and structured follow-up after surgery.
Why follow-up matters
Many avoidable problems after bariatric surgery are related to hydration, nutrition, medication adjustment, and follow-up adherence. After surgery, patients need regular monitoring of:
- Body weight and body composition
- Glucose and diabetes medications
- Blood pressure and antihypertensive medications
- Iron, vitamin B12, vitamin D, calcium, albumin, and other nutritional markers
- Reflux symptoms or abdominal pain
- Eating pattern, protein intake, and physical activity
For international patients, follow-up planning is especially important. A good program should provide clear postoperative instructions, medication adjustment guidance, nutrition plans, and coordination with local physicians after returning home. See our safety & follow-up process page and the guide for international patients.
Key message for international patients
Korean bariatric surgery is supported by national clinical data, specialist surgical teams, and a structured healthcare system. Recent Korean studies report meaningful weight loss, high remission rates of type 2 diabetes, and low short-term serious-complication rates in selected patients.
However, the safest surgery is not simply the fastest or cheapest option. It is the one performed after careful assessment, with the right procedure selected for the right patient, and with a clear postoperative follow-up plan.
Safety considerations for patients with diabetes
Patients with type 2 diabetes may need additional preoperative evaluation, including HbA1c review, kidney function, cardiovascular risk assessment, medication adjustment, and postoperative glucose monitoring.
Learn how surgery may affect diabetes in our bariatric surgery for type 2 diabetes guide, and prepare your records using the medical records checklist.
Frequently asked questions
Is bariatric surgery safe in Korea?
Recent Korean multicenter studies report favorable short-term safety outcomes in selected patients. In one prospective multicenter study, no deaths occurred, early postoperative complications were reported in 0.9% of patients, and no Clavien–Dindo grade III or higher complications were observed. Safety still depends on patient selection, surgical expertise, and follow-up.
Is bariatric surgery covered by Korean national insurance?
For Korean residents who meet eligibility criteria, bariatric surgery has been covered by the Korean National Health Insurance Service since 2019. Coverage applies to patients with BMI ≥ 35 kg/m², or ≥ 30 kg/m² with obesity-related comorbidities. Partial reimbursement is available for selected patients with type 2 diabetes and BMI 27.5–30 kg/m². International self-paid patients are not covered by Korean national insurance.
Which bariatric surgery is most common in Korea?
Sleeve gastrectomy is the most commonly performed bariatric procedure in Korea. National data from 2019 to 2022 showed that sleeve gastrectomy accounted for approximately 75% of bariatric surgery cases.
Can older patients have bariatric surgery?
Older patients may be considered for bariatric surgery after careful evaluation. A Korean multicenter study found that patients aged 55 or older had no significant increase in complication rate, readmission, reoperation, or mortality compared with younger patients. However, frailty, nutritional status, cognitive capacity, and organ function should be assessed before surgery.
Does bariatric surgery improve diabetes?
Yes, bariatric and metabolic surgery can significantly improve type 2 diabetes in selected patients. In a Korean prospective multicenter study, type 2 diabetes remission was 80.7% at 1 year and 85.7% at 2 years after surgery. Remission is not a cure and long-term follow-up remains necessary.
What follow-up is needed after surgery?
Follow-up should include body weight monitoring, diabetes and blood pressure medication adjustment, nutrition assessment, vitamin and mineral supplementation, and screening for symptoms such as reflux, abdominal pain, dehydration, or anemia. Long-term follow-up is essential for both safety and weight maintenance.
Medical disclaimer
This page is general health information, not medical advice, diagnosis, or treatment. The figures cited are from population-level Korean studies and national data and may not apply to any individual; they are not outcomes promised to any patient. Bariatric surgery carries surgical and nutritional risks. Whether it is appropriate can only be determined by a licensed specialist after full evaluation. NextWeight is a DYPHI-operated coordination and preliminary review support service and does not provide diagnosis, treatment, or surgical procedures directly.